BiotechTube

Longeveron Mesenchymal Stem Cells (LMSCs) + Fluzone High Dose Vaccine

Phase 1/2Completed
0 watching 0 views this week💤 Quiet
33
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Aging Frailty

Conditions

Aging Frailty

Trial Timeline

Nov 1, 2016 → Sep 1, 2022

NCT ID
NCT02982915

About Longeveron Mesenchymal Stem Cells (LMSCs) + Fluzone High Dose Vaccine

Longeveron Mesenchymal Stem Cells (LMSCs) + Fluzone High Dose Vaccine is a phase 1/2 stage product being developed by Longeveron for Aging Frailty. The current trial status is completed. This product is registered under clinical trial identifier NCT02982915. Target conditions include Aging Frailty.

Hype Score Breakdown

Clinical
13
Activity
8
Company
2
Novelty
4
Community
3

Clinical Trials (1)

NCT IDPhaseStatus
NCT02982915Phase 1/2Completed

Competing Products

20 competing products in Aging Frailty

See all competitors
ProductCompanyStageHype Score
HRS-9231 + GadobutrolJiangsu Hengrui MedicinePhase 2
52
HRS-1738 InjectionJiangsu Hengrui MedicinePhase 1/2
41
fluvastatinNovartisPhase 2
52
Ranolazine + Placebo to match ranolazineGilead SciencesApproved
84
CP-424,391PfizerPhase 2
51
Gemcitabine-Releasing Intravesical System (GemRIS)/TAR-200 + Nivolumab Injection [Opdivo]Bristol Myers SquibbPhase 1
32
injectable poly-L-lactic acidSanofiApproved
84
Gadobutrol (Gadavist/Gadovist, BAY86-4875)BayerPre-clinical
20
Gadobutrol (Gadovist, BAY86-4875) + Gadopentetate Dimeglumine (Magnevist, BAY86-4882)BayerPhase 3
74
Iopromide (Ultravist, BAY86-4877)BayerPre-clinical
20
Gadoquatrane (BAY1747846)BayerPhase 3
74
BAY86-4367 + BAY86-4367BayerPhase 1
30
GBCAsBayerPre-clinical
20
Gadobutrol (Gadovist, BAY86-4875)BayerPhase 3
74
BAY1747846BayerPhase 1
30
Gadoterate (Dotarem/Clariscan) + Gadobutrol (Gadavist/Gadovist, BAY86-4875)BayerApproved
82
Gadoquatrane (BAY1747846) + Gadobutrol + Gadoterate meglumine + GadoteridolBayerPhase 3
74
Gadobutrol (Gadovist, BAY86-4875)BayerPre-clinical
20
F-18 DPA-714 (BAY85-8102) + F-18 DPA-714 (BAY85-8102) + F-18 DPA-714 (BAY85-8102)BayerPhase 1
30
Gadopentetate dimeglumine (Magnevist, BAY86-6661)BayerPhase 3
74

Other Products from Longeveron

Allogeneic MSCPhase 2
44
Longeveron Mesenchymal Stem Cells (LMSCs)Phase 2
44
Lomecel-B medicinal signaling cellsPhase 2
44
Peripheral Intravenous (IV) infusion of LMSCsPhase 2
44
Longeveron Mesenchymal Stem CellsPhase 1/2
33